Oxidative Stress, Glutamate, and Neurodegenerative Disorders
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
There is an increasing amount of experimental evidence that oxidative stress is a causal, or at least an ancillary, factor in the neuropathology of several adult neurodegenerative disorders, as well as in stroke, trauma, and seizures. At the same time, excessive or persistent activation of glutamate-gated ion channels may cause neuronal degeneration in these same conditions. Glutamate and related acidic amino acids are thought to be the major excitatory neurotransmitters in brain and may be utilized by 40 percent of the synapses. Thus, two broad mechanisms—oxidative stress and excessive activation of glutamate receptors—are converging and represent sequential as well as interacting processes that provide a final common pathway for cell vulnerability in the brain. The broad distribution in brain of the processes regulating oxidative stress and mediating glutamatergic neurotransmission may explain the wide range of disorders in which both have been implicated. Yet differential expression of components of the processes in particular neuronal systems may account for selective neurodegeneration in certain disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and inflammation are early events of neurodegenerative diseases [920,944-957]”
In the citing paper
“lipid peroxidation could be a major feature of ferroptosis in AD”
In the citing paper
“the brain contains the high levels of polyunsaturated fatty acids (PUFAs) in its membrane rich architecture”
In the citing paper
“The pathophysiology of depression is multifactorial and includes changes in brain monoaminergic transmission (e.g., 5-HT, NE, DA), abnormalities in neurotransmitter receptors function (e.g., AC-cAMP pathway), reduced neurotrophic factors (e.g., BDNF), dysregulation of HPA axis (cortisol), increased proinflammatory cytokines (e.g., IL-6, TNF-α, NF-κB), increased NO (e.g., L-arginine-NO-cGMP pathway”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [45]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Glutamate: A Neurotransmitter in Mammalian Brain
Fonnum, F. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09689.x · Cited by 1,992
Research works printed but not linked: 8
- CHAN, P.H., REDUCED NEUROTOXICITY IN TRANSGENIC MICE OVEREXPRESSING HUMAN COPPER-ZINC SUPEROXIDE-DISMUTASE, STROKE 21: 80 (1990).
- CHOI, D.W., METHODS FOR ANTAGONIZING GLUTAMATE NEUROTOXICITY, CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 2: 105 (1990).
- DICHTER, M, EPILEPSIA 30: S3 (1989).
- HALLIWELL, B, ACTA NEUROLOGICA SCANDINAVICA 80 126: 23 (1989).
- JENNER, P, OXIDATIVE STRESS AS A CAUSE OF PARKINSONS-DISEASE, ACTA NEUROLOGICA SCANDINAVICA 84: 6 (1991).
- Olney, J. W., Kainic Acid as a Tool in Neurobiology: 95 (1978).
- SIESJO, B. K., CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 1: 165 (1989).
- TELLEZ-NAGEL, I, ADVANCES IN NEUROLOGY 1: 387 (1973).
Cited by
Items 801–900 of 1,019
Fernsebner, K., Zorn, J., Kanawati, B., Walker, A., & Michalke, B. (2014) · Metallomics · doi:10.1039/c4mt00022f · Cited by 103
Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown, D. R. (2005) · PubMed · Cited by 118
Vascular dementia: pharmacological treatment approaches and perspectives.
Baskys, A., & Hou, A. C. (2007) · PubMed · Cited by 114
Saporito, M. S., Hudkins, R. L., & Maroney, A. C. (2002) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70081-x · Cited by 108
Protection Against Oxidative Stress‐induced Neuronal Cell Death‐A Novel Role for RU486
Behl, C., Trapp, T., Skutella, T., & Holsboer, F. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01442.x · Cited by 98
Peterson, D. A., Lucidi‐Phillipi, C. A., Murphy, D., Ray, J., & Gage, F. H. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-00886.1996 · Cited by 98
Shah, S. A., Amin, F. U., Khan, M., Abid, N. B., Rehman, S. U., Kim, T. H., Kim, M. W., & Kim, M. O. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0752-y · Cited by 97
“This process is similar in nature to numerous neurodegenerative diseases and some pathological conditions, such as ischemia and trauma [3, 48, 49].”
BackgroundWang, J., Liu, Y., Cao, W., Yao, K., Liu, Z.-Q., & Guo, J. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9282-1 · Cited by 99
“Decline in GSH levels could either increase or reflect oxidative status (Coyle and Puttfarcken 1993; Bains and Shaw 1997).”
BackgroundQuercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia
Naidu, P. S., Singh, A., & Kulkarni, S. K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00101-1 · Cited by 108
Memory enhancing and neuroprotective effects of selected ginsenosides
Bao, H. Y., Zhang, J., Yeo, S. J., Myung, C., Kim, H. M., Kim, J., Park, J. H., Cho, J., & Kang, J. S. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977802 · Cited by 99
Mitochondrial dysfunction and oxidative stress in seizure-induced neuronal cell death.
Chuang, Y. (2010) · PubMed · Cited by 114
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model
Tapias, V., Cannon, J. R., & Greenamyre, J. T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22201 · Cited by 97
“Oxidative stress is thought to be a significant contributing factor to PD pathogenesis (Jenner, 1992; Coyle and Puttfarcken, 1993).”
BackgroundNeuroprotective Effects of Garlic A Review
Mathew, B., & Biju, R. S. (2008) · Libyan Journal of Medicine · doi:10.4176/071110 · Cited by 112
Harish, B. S., Uppuluri, K. B., & Veerappan, A. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.06.069 · Cited by 97
Miele, M., Boutelle, M. G., & Fillenz, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90316-6 · Cited by 97
Oxidative reactions and schizophrenia: A review-discussion
Smythies, J. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00005-4 · Cited by 103
“, 1995), and there is evidence that ROS play a key role in both NMDA- and nonNMDA-mediated neurotoxicity (Dykens et al., 1987; Coyle and Puttfarcken, 1993; Favit et al., 1993; Lafon-Cazal et al., 1993; Rothman and Olney, 1995; Patel et al., 1996).”
BackgroundBiochemical changes associated with selective neuronal death following short-term cerebral ischaemia
Sims, N. R., & Zaidan, E. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00026-l · Cited by 108
Przedborski, S., Donaldson, D., Jakowec, M., Kish, S. J., Guttman, M., Rosoklija, G., & Hays, A. P. (1996) · Annals of Neurology · doi:10.1002/ana.410390204 · Cited by 95
Tikka, T., Usenius, T., Tenhunen, M., Keinänen, R., & Koistinaho, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00543.x · Cited by 96
Samad, N., Jabeen, S., Imran, I., Zulfiqar, I., & Bilal, K. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00432-1 · Cited by 97
Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis
Corona, J. C., Tovar-y-Romo, L. B., & Tapia, R. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1415 · Cited by 92
“These events potentiate each other in a cascade manner to produce membrane damage and, consequently, cell death [3,5,31,32] .”
BackgroundMelatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation
Manda, K., & Reiter, R. J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.019 · Cited by 103
GSM Base Station Electromagnetic Radiation and Oxidative Stress in Rats
Yurekli, A. I., Özkan, M., Kalkan, T., Saybaşılı, H., Tuncel, H., Atukeren, P., Gümüştaş, K., & Seker, S. S. (2006) · Electromagnetic Biology and Medicine · doi:10.1080/15368370600875042 · Cited by 96
“GSH-Px also participates in detoxification of lipid peroxyl radicals (Coyle and Puttfarcken, 1993; Stadtman, 1998).”
BackgroundKim, S. R., Park, M. J., Lee, M. K., Sung, S. H., Park, E., Kim, J., Kim, S. Y., Oh, T. H., Markelonis, G. J., & Kim, Y. C. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00751-7 · Cited by 102
Christie, S., Comeau, B., Myers, T. L., Sadi, D., Purdy, M., & Mendez, I. M. (2008) · Neurosurgical FOCUS · doi:10.3171/foc.2008.25.11.e5 · Cited by 102
Reversal of Aging and Chronic Ethanol-induced Cognitive Dysfunction by Quercetin a Bioflavonoid
Singh, A., Naidu, P. S., & Kulkarni, S. K. (2003) · Free Radical Research · doi:10.1080/10715760310001616014 · Cited by 95
“oxygen and hydroxyl radicals provide the first line of antioxidant defense in the brain.([25]) Previous studies have shown that the increased free radical generation during aging and in ethanol intoxication was associated with decreased cellular GSH levels, which can be reversed by antioxidants.”
BackgroundKim, J.-S., Shin‐ya, K., Furihata, K., Hayakawa, Y., & Seto, H. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)00638-2 · Cited by 96
Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain
Mo, J. Q., Hom, D. G., & Andersen, J. K. (1995) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(95)01586-o · Cited by 96
Namura, S., Nagata, I., Takami, S., Masayasu, H., & Kikuchi, H. (2001) · Stroke · doi:10.1161/01.str.32.8.1906 · Cited by 95
Loss of inwardly rectifying potassium currents by human retinal glial cells in diseases of the eye
Francke, M., Pannicke, T., Biedermann, B., Faude, F., Wiedemann, P., Reichenbach, A., & Reichelt, W. (1997) · Glia · doi:10.1002/(sici)1098-1136(199707)20:3<210::aid-glia5>3.0.co;2-b · Cited by 98
“Thus, via determination of the MC membrane potential, the inwardly rectifying K1 channels directly influence the extracellular glutamate concentration, which is a very critical parameter for normal neuronal function since glutamate is well known to be neurotoxic at higher concentrations (Coyle and Puttfarcken, 1993).”
BackgroundNakao, N., & Brundin, P. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00223-0 · Cited by 96
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
“Elevated levels of glutamate act on extrasynaptic NMDA receptors leading to an influx of Ca into the neurons, which results in the toxic accumulation of reactive oxygen species (ROS) [198], with increased nitric oxide (NO) production playing a key role in MD pathology and treatment response [199, 200].”
BackgroundNeuronal Responses to Physiological Stress
Kagias, K., Nehammer, C., & Pocock, R. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00222 · Cited by 105
“Neurons are particularly vulnerable to oxidative stress, which can lead to neuronal cell death associated with many agerelated neurodegenerative diseases (Coyle and Puttfarcken, 1993; Andersen, 2004).”
BackgroundKawakami, Z., Kanno, H., Ikarashi, Y., & Kase, Y. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.11.063 · Cited by 95
“…in various pathologic conditions including ischemia Choi and Rothman, 1990), trauma (Hayes et al., 1992), epileptic eizures (Rothman and Olney, 1987), and neurodegenerative disrders such as Alzheimer’s, Parkinson’s, and Huntington’s diseases Monaghan et al., 1989; Coyle and Puttfarcken, 1993).”
BackgroundSaransaari, P., & Oja, S. S. (1998) · Neurochemical Research · doi:10.1023/a:1022494921018 · Cited by 95
“Free radicals and excitatory amino acids cooperate further in the genesis of ischemia-induced neuronal damage (3, 8 ).”
Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity
Ran, Q., Gu, M., Van Remmen, H., Strong, R., Roberts, J. L., & Richardson, A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20868 · Cited by 93
“Because of the importance of lipid peroxidation in oxidative injury to neurons (Coyle and Puttfarcken, 1993) and because of Gpx4 can directly reduce lipid hydroperoxides formed in membranes, we were interested in determining the effect of overexpressing Gpx4 on the sensitivity of neurons to oxidative stress.”
BackgroundInfluentialDependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation
Li, Q., Pedersen, C., Day, B. J., & Patel, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00457.x · Cited by 96
Kim, S., Park, Y., Min, J., Sun, H.-N., Han, Y., Hua, J.-M., Lee, T., Lee, S., Chang, K.-T., Kang, S. W., et al. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.03.006 · Cited by 100
“To define the relationship between oxidative stress and neurodegeneration, expression profiles of antioxidants have been obtained in brain tissues from a variety of patients including ones with Parkinson's (PD) and Alzheimer's (AD) diseases (Coyle and Puttfarcken, 1993; Krapfenbauer et al., 2002; Krapfenbauer et al.,…”
Simantov, R., Crispino, M., Hoe, W., Broutman, G., Tocco, G., Rothstein, J. D., & Baudry, M. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00349-0 · Cited by 94
Baud, O., Haynes, R. F., Wang, H., Folkerth, R. D., Li, J., Volpe, J. J., & Rosenberg, P. A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03451.x · Cited by 91
de Bernardo, S., Canals, S., Casarejos, M. J., Solano, R. M., Menendez, J., & Mena, M. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02744.x · Cited by 98
“Reactive oxygen species (ROS) have been implicated in a number of neurological disorders including PD (Coyle and Puttfarcken 1993; Di Monte 2001).”
BackgroundHornbein, T. F. (2001) · Journal of Experimental Biology · doi:10.1242/jeb.204.18.3129 · Cited by 106
Slemmon, J. R., Morgan, J. I., Fullerton, S. M., Danho, W., Hilbush, B. S., & Wengenack, T. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15911 · Cited by 94
Glutamate in schizophrenia: clinical and research implications
GOFF, D. C., & Wine, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00079-0 · Cited by 105
“Second, the excitatory amino acids also play a critical role in neurotoxicity, whether occurring as a consequence of hypoxic injury or as programmed cell death, or 'apoptosis', in which excessive ceils are 'pruned' during brain development (Choi, 1988; Coyle and Puttfarcken, 1993).”
BackgroundCognitive dysfunction in schizophrenia: unifying basic research and clinical aspects
McCarley, R. W., Niznikiewicz, M. A., Salisbury, D. F., Nestor, P. G., O’Donnell, B. F., Hirayasu, Y., Grunze, H., Greene, R. W., & Shenton, M. E. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014188 · Cited by 102
“excitotoxic damage to cells (likely primarily confined to the dendritic tree rather than cellular loss) (Coyle 1996; Coyle and Puttfarcken 1993; McCarley et al. 1991; Olney 1990).”
Cunningham, M. G., Bhattacharyya, S., & Benes, F. M. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm183 · Cited by 93
“After removal from the skull, brains were postfixed in the same fixative for 12 h, and Vibratome sections were cut with a thickness of 50 lm in the coronal plane.”
Age-Dependent and Tissue-Related Glutathione Redox Status in a Mouse Model of Alzheimer's Disease
Zhang, C., Rodriguez, C., Spaulding, J., Aw, T. Y., & Feng, J. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111244 · Cited by 89
“species (ROS) and a disturbance of glutathione ( ∗ Correspondence to: JuneFeng,DepartmentofBiomedicalEngi-neering,LouisianaTechUniversity,818NelsonAvenue,Ruston junefeng@latech.edu. protects cells from oxidative stress [4, 5].”
Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus
Gao, Z., Chen, X., & Hu, G. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.096 · Cited by 93
Production and Toxicity of the Marine Biotoxin Domoic Acid and Its Effects on Wildlife: A Review
Bejarano, A. C., VanDola, F. M., Gulland, F. M. D., Rowles, T. K., & Schwacke, L. H. (2008) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/10807030802074220 · Cited by 105
“Glutamic acid is one of the main excitatory neurotransmitters of the central nervous system, present in nearly 40% of all neuronal synaptic sites (Coyle and Puttfarcken 1993).”
BackgroundAllen, J. W., Mutkus, L. A., & Aschner, M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02375-7 · Cited by 98
Das, A., McDowell, M., Pava, M. J., Smith, J. A., Reiter, R. J., Woodward, J. J., Varma, A. K., Ray, S. K., & Banik, N. L. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00739.x · Cited by 93
“Oxidative stress, glutamate-induced excitotoxicity, and tumor necrosis factor-a (TNF-a)-induced cytotoxicity have been suggested to play a key role in most forms of neurodegeneration, including ischemic brain damage, trauma, Alzheimer s disease, alcoholic degeneration, and other diseases [33].”
BackgroundHong, J.-T., Yen, J.-H., Wang, L., Lo, Y., Chen, Z., & Wu, M. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.02.014 · Cited by 97
Oxidative stress in patients with epilepsy is independent of antiepileptic drugs
Menon, B., Ramalingam, K., & Kumar, R. V. (2012) · Seizure · doi:10.1016/j.seizure.2012.09.003 · Cited by 93
Болдырев, А. А., Song, R., Lawrence, D. A., & Carpenter, D. O. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00273-0 · Cited by 97
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722601.x · Cited by 90
Increased Cerebral Free Radical Production During Thiamine Deficiency
Langlais, P. J., Anderson, G. W., Guo, S. X., & Bondy, S. C. (1997) · Metabolic Brain Disease · doi:10.1007/bf02674735 · Cited by 93
“However, seizures are often associated with excitotoxins which by themselves cause excessive production of oxygen free radicals through activation of NMDA receptors ( Coyle and Puttfarcken, 1993 ).”
BackgroundMorrison, B. M., Gordon, J. W., Ripps, M. E., & Morrison, J. H. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960930)373:4<619::aid-cne9>3.0.co;2-4 · Cited by 89
Lawrence, M. S., Ho, D. Y., Dash, R., & Sapolsky, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7247 · Cited by 93
A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease
Shults, C. W., Haas, R. H., & Beal, M. F. (1999) · BioFactors · doi:10.1002/biof.5520090223 · Cited by 91
Reactive oxygen species in status epilepticus
Shekh‐Ahmad, T., Kovac, S., Abramov, A. Y., & Walker, M. C. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.07.011 · Cited by 97
“Subsequent evidence indicated that ROS play a role in this excitotoxic damage[20], and later, ROS production was shown to be necessary for excitotoxic neuronal injury[21].”
BackgroundLi, J., Jaiswal, M. K., Chien, J.-F., Kozlenkov, A., Jung, J., Zhou, P., Gardashli, M., Pregent, L., Engelberg-Cook, E., Dickson, D. W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41033-y · Cited by 96
Carvedilol attenuates neuroleptic‐induced orofacial dyskinesia: possible antioxidant mechanisms
Naidu, P. S., Singh, A., & Kulkarni, S. K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704717 · Cited by 92
Kamat, P. K., Tota, S., Saxena, G., Shukla, R., & Nath, C. (2009) · Brain Research · doi:10.1016/j.brainres.2009.10.064 · Cited by 94
Yang, H., Chang, W.-H., Chia, Y., Huang, C.-J., Lu, F., Hsu, H., & Hseu, Y. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.06.027 · Cited by 92
Nakabeppu, Y., Kajitani, K., Sakamoto, K., Yamaguchi, H., & Tsuchimoto, D. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.03.003 · Cited by 102
Attenuation of 6‐OHDA‐induced neurotoxicity in glutathione peroxidase transgenic mice
Bensadoun, J. C., Mirochnitchenko, O., Inouye, M., Aebischer, P., & Zurn, A. D. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00345.x · Cited by 88
“E-mail: Anne.Zurn@chuv.hospvd.ch Received 21 November 1997, revised 13 March 1998, accepted 27 May 1998 proposed to contribute to pathological cell death in neurodegenerative diseases and, in particular, in PD (Coyle & Puttfarcken, 1993).”
BackgroundChengappa, K. N. R., Turkin, S. R., DeSanti, S., Bowie, C. R., Brar, J. S., Schlicht, P. J., Murphy, S. L., Hetrick, M. L., Bilder, R. M., & Fleet, D. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.001 · Cited by 95
“…remain elusive, glutamate excitotoxicity and NMDA (N-methyl-D-aspartate) receptor hypofunction (Smythies, 1999; Javitt, 2006) combined with impaired cellular antioxidant defenses (Coyle and Puttfarcken, 1993; Yao et al., 2001) offer testable possibilities for improving executive dysfunction.”
BackgroundInfluentialGiordano, G., White, C. C., McConnachie, L. A., Fernández, C., Kavanagh, T. J., & Costa, L. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027748 · Cited by 97
“Evidence accumulated over the past several years indicates that activation of ionotropic glutamate receptors may be an important source of oxidative stress leading to selective neuronal damage (Coyle and Puttfarcken, 1993).”
Kawaguchi, K., Hickey, R. W., Rose, M. E., Zhu, L., Chen, J., & Graham, S. H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.038 · Cited by 92
Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain
Mallard, C. E., Waldvogel, H. J., Williams, C., Faull, R. L. M., & Gluckman, P. D. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00504-x · Cited by 97
Jin, B. K., Shin, D. Y., Jeong, M. Y., Gwag, M. R., Baik, H. W., Yoon, K. S., Cho, Y. H., Joo, W. S., Kim, Y. S., & Baik, H. H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00170-0 · Cited by 92
Lin, L., Cao, S., Yu, L., Cui, J., Hamilton, W. J., & Liu, P. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741098.x · Cited by 101
“Ischemia–reperfusion perturbs the oxygen supply and energy metabolism of the brain, causing oxidative stress by generating free radicals (Coyle and Puttfarcken, 1993).”
BackgroundTamatani, M., Ogawa, S., & Tohyama, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00095-3 · Cited by 92
Lockhart, B. P., Benicourt, C., Junien, J. ‐., & Privat, A. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390416 · Cited by 92
Deschamps, V., Barberger-Gateau, P., Peuchant, E., & Orgogozo, J. M. (2001) · Neuroepidemiology · doi:10.1159/000054752 · Cited by 91
Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
Gonsette, R. E. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507080111 · Cited by 103
“death [2] and, importantly, the central role of”
BackgroundDevelopmental Neurotoxicity of Arsenic: Involvement of Oxidative Stress and Mitochondrial Functions
Chandravanshi, L. P., Gupta, R., & Shukla, R. K. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1286-1 · Cited by 95
“Generation of ROS in the mitochondrial respiratory chain has been linked to neurotoxicity-associated changes in the CNS through the impairment in mitochondrial functions and neuronal homeostasis.”
Kumar, B., Kumar, V., Prashar, V., Saini, S., Dwivedi, A. R., Bajaj, B., Mehta, D., Parkash, J., & Kumar, V. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.039 · Cited by 91
Oxidative stress: A target to treat Alzheimer's disease and stroke
Briyal, S., Ranjan, A. K., & Gulati, A. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105509 · Cited by 94
Hewett, S. J., Bell, S. C., & Hewett, J. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.011 · Cited by 100
Novel markers of oxidative stress in actively progressive HIV dementia
Sacktor, N. C., Haughey, N. J., Cutler, R. G., Tamara, A., Turchan-Cholewo, J. T., Pardo, C. A., Vargas, D. L., & Nath, A. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.037 · Cited by 98
“Reactive oxygen species have been implicated in the pathogenesis of several neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS; Cherayil and Cyrus, 1966; Coyle and Puttfarken, 1993;Cutler et al., 2002; France-Lanord et al., 1997;…”
BackgroundAliev, G., Seyidova, D., Lamb, B. T., Obrenovich, M. E., Siedlak, S. L., Vinters, H. V., Friedland, R. P., Siedlak, S. L., Vinters, H. V., Friedland, R. P., et al. (2003) · Neurological Research · doi:10.1179/016164103101201977 · Cited by 91
ALIEV, G., SEYIDOVA, D., NEAL, M. L., SHI, J., LAMB, B. T., SIEDLAK, S. L., VINTERS, H. V., HEAD, E., PERRY, G., LAMANNA, J. C., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04798.x · Cited by 90
Boland, K., Behrens, M., Choi, D., Manias, K., & Perlmutter, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18032 · Cited by 89
Giannakopoulos, P., Kövari, E., French, L. E., Viard, I., Hof, P. R., & Bouras, C. (1998) · Acta Neuropathologica · doi:10.1007/s004010050815 · Cited by 90
“Alternatively, clusterin associates with lipids and proteins capable of preventing lipid peroxidation in vivo [4, 15, 33], and may, therefore, prevent oxidative stress which plays an important role in neuronal degeneration and death in AD [2, 12, 26, 53, 54].”
BackgroundIntersection between metabolic dysfunction, high fat diet consumption, and brain aging
Uranga, R. M., Bruce‐Keller, A. J., Morrison, C. D., Fernandez‐Kim, S. O., Ebenezer, P. J., Zhang, L., Dasuri, K., & Keller, J. N. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06803.x · Cited by 87
“…glutamate signaling occurring in the aging brain, especially in age-related disorders such as AD, culminating in the development of neuron death through excitotoxicity (Coyle et al. 1981; Mattson et al. 1992, 1995a,b; Coyle and Puttfarcken 1993; Sattler and Tymianski 2000; Hynd et al. 2004).”
BackgroundIntegrated biomarker responses in zebrafish exposed to sulfonamides
Lin, T., Yu, S., Chen, Y., & Chen, W. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.07.020 · Cited by 92
Sahara, N., Maeda, S., Yoshiike, Y., Mizoroki, T., Yamashita, S., Murayama, M., Park, J. ‐., Saito, Y., Murayama, S., & Takashima, A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21417 · Cited by 88
“including AD, and the aging process is associated with gradual accumulation of oxidative stress factors (Coyle and Puttfarcken, 1993), it seems reasonable that the overriding of oxidative insults disables molecular chaperones.”
BackgroundInfluentialAiraksinen, M. S., Thoenen, H., & Meyer, M. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01360.x · Cited by 90
“…(Ca2+) which exceeds the physiological limits of neuronal Ca2+-handling ability, is a common step in various neurodegenerative processes, and may be accompanied by increased oxidative stress and radical formation (Coyle and Puttfarken, 1993; Olanow, 1993; Orrenius and Nicotera, 1994; Choi, 1995).”
BackgroundAntioxidant treatment protects striatal neurons against excitotoxic insults
Nakao, N., Grasbon-Frodl, E. M., Widner, H., & Brundin, P. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00034-6 · Cited by 90
Inhibition of Astrocyte Glutamate Uptake by Reactive Oxygen Species: Role of Antioxidant Enzymes
Sorg, O., Horn, T. F. W., Yu, N., Gruol, D. L., & Bloom, F. E. (1997) · Molecular Medicine · doi:10.1007/bf03401690 · Cited by 92
The Role of SLC7A11 in Cancer: Friend or Foe?
Li, S., Lu, Z., Sun, R., Guo, S., Gao, F., Cao, B., & Aa, J. (2022) · Cancers · doi:10.3390/cancers14133059 · Cited by 94
“Glutamate could also act as an excitatory neurotransmitter and participate in either neuronal signalling or excitotoxic pathology [4,11,12].”
BackgroundThe Consequences of Methylmercury Exposure on Interactive Functions between Astrocytes and Neurons
Allen, J. W., Shanker, G., Tan, K. H., & Aschner, M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(01)00076-6 · Cited by 89
Baek, B. S., Kwon, H. J., Lee, K. H., Yoo, M. A., Kim, K. W., Ikeno, Y., Yu, B. P., & Chung, H. Y. (1999) · Archives of Pharmacal Research · doi:10.1007/bf02979058 · Cited by 97
In vitro antioxidant activity of Diospyros malabarica Kostel bark.
Mondal, S. K., Chakraborty, G., Gupta, M., & Mazumder, U. K. (2006) · PubMed · Cited by 89
Delayed Antagonism of Calpain Reduces Excitotoxicity in Cultured Neurons
Brorson, J. R., Marcuccilli, C. J., & Miller, R. J. (1995) · Stroke · doi:10.1161/01.str.26.7.1259 · Cited by 89
Kainic acid induces apoptosis in neurons
Simonian, N. A., Getz, R. L., Leveque, J., Konradi, C. L., & Coyle, J. T. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00326-0 · Cited by 91
Self-citationSamanta, S., Perkinton, M. S., Morgan, M., & Williams, R. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052082.x · Cited by 93
“…to influence the neuropathology of numerous neurodegenerative disorders including Alzheimer’s disease (Behi et al., 1994) and Parkinson’s disease (Fahn and Cohen, 1992) and may be involved in excitotoxic neuronal cell death (Coyle and Puttfarcken, 1993; Dubinsky et al., 1995; Patel et al., 1996).”
BackgroundMyeloperoxidase Is Involved in H2O2-induced Apoptosis of HL-60 Human Leukemia Cells
Wagner, B. A., Buettner, G. R., Oberley, L. W., Darby, C. J., & Burns, C. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001434200 · Cited by 90
Ikegaya, Y., Kim, J.-A., Baba, M., Iwatsubo, T., Nishiyama, N., & Matsuki, N. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.22.4083 · Cited by 88
Metadata
- Authors
- Coyle, J. T., & Puttfarcken, P.
- Affiliations
- Harvard University (US)
- ORCID
- Coyle, Joseph T.
- Venue
- Science
- Published
- 1993-10-29
- Volume
- 262
- Issue
- 5134
- Pages
- 689-695
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2016293448
- Cited by
- 3,762
- References
- 104
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 56 · 2023: 58 · 2022: 51 · 2021: 66 · 2020: 74 · 2019: 83 · 2018: 89 · 2017: 104 · 2016: 105 · 2015: 99 · 2014: 158 · 2013: 126 · 2012: 137
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, glutamate, neurodegenerative diseases, glutamate receptors, excitotoxicity, glutamatergic neurotransmission, neurodegeneration, stroke, traumatic brain injury, seizures, selective neurodegeneration, acidic amino acids
- MeSH terms
- Animals, Brain, Glutamates, Humans, Nervous System Diseases, Reactive Oxygen Species, Receptors, Glutamate, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.